Effects of saffron (Crocus sativus L.) supplementation on cardiometabolic Indices in diabetic and prediabetic overweight patients: a systematic review and meta-analysis of RCTs
Mehdi Karim, Samira Pirzad, Niyousha Shirsalimi, Mohammad Hossein Hosseini, Pouya Ebrahimi, Sara khoshdooz, Pegah Rashidian · 2024
Read Effects of saffron (Crocus sativus L.) supplementation on cardiometabolic Indices in diabetic and prediabetic overweight patients: a systematic review and meta-analysis of RCTs by Mehdi Karim, Samira Pirzad, Niyousha Shirsalimi, Mohammad Hossein Hosseini, Pouya Ebrahimi, Sara khoshdooz, Pegah Rashidian (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11600967.txt.
Description
Mehdi Karim and co-authors pool trial results on saffron for people with diabetes in this 2024 review. Saffron is a spice with a long history in traditional medicine. Interest has grown in whether it can improve the blood markers that drive heart and metabolic risk.
Fifteen trials with eight hundred sixty-nine overweight patients with diabetes or prediabetes were combined. Saffron clearly lowered fasting blood sugar, a long-term sugar marker, blood fats of one kind, and top blood pressure. It also lowered a liver enzyme linked to strain. No clear effect appeared for insulin output, cholesterol measures, or kidney markers. The authors judge saffron a helpful add-on for some markers. They call for more trials with longer follow-up to firm up the picture.
Catalog record
| CREATOR | Mehdi Karim, Samira Pirzad, Niyousha Shirsalimi, Mohammad Hossein Hosseini, Pouya Ebrahimi, Sara khoshdooz, Pegah Rashidian |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |